Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 95.00
-3.00 (-3.06%)
May 12, 2026, 3:30 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 6.9 billion as of May 12, 2026. Its market cap has decreased by -19.17% in one year.
Market Cap
6.90B
Enterprise Value
5.78B
Revenue
593.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
95.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 6.90B, an increase of 1,368.24%. That is a compound annual growth rate of 20.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.12B | -2.22% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.71B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.56B |
| ADR120S | 7.31B |
| CellSource | 7.18B |
| TMS Co., Ltd. | 6.87B |